The efficacy and safety of CAR-T cell therapy in patients with refractory ALL and concomitant HBV infection.
Peilong LaiXiaomei ChenLe QinZhiwu JiangChenwei LuoXin HuangSujing WuWei LingYulian WangJinghua WangChenxin DengLisi HuangLingji ZengZesheng LuLiye ZhongPengjun LiaoMinming LiDongmei ChenSuxia GengPing WuZhaoyang TangDuan-Qing PeiXin DuPeng LiJianyu WengPublished in: Leukemia (2020)